PTU - Polskie Towarzystwo Urologiczne
list of articles:

Atypical small acinar proliferation (ASAP) and prostatic intraepitelial neoplasia (PIN) as precancerous lesions in patients with suspicion and prostate cancer
Article published in Urologia Polska 2008/61/3.

authors

Przemysław Adamczyk, Zbigniew Wolski, Romuald Butkiewicz, Joanna Nussbeutel, Zdzisław Skok, Wojciech Jóźwicki
Oddział Urologii Ogólnej i Onkologicznej Specjalistycznego Szpitala Miejskiego w Toruniu
Katedra i Klinika Urologii Ogólnej, Onkologicznej i Dzieci Collegium Medicum Uniwersytetu Mikołaja Kopernika w Bydgoszczy
Zakład Patomorfologii Specjalistycznego Szpitala Miejskiego w Toruniu
Katedra i Zakład Patomorfologii Collegium Medicum Uniwersytetu Mikołaja Kopernika w Bydgoszczy

keywords

atypical small acinar proliferation (ASAP) Prostatic Intraepitelial Neoplasia (PIN) precancerous lesions of prostate cancer

summary

Introduction.

Association of high grade prostatic intraepitelial neoplasia (HG-PIN) and atypical small acinar proliferation (ASAP) with cancer development is still not clear, particularly in case of ASAP. The aim of the study. The aim of the was to establish a prevalence of precancerous lesions, and prostate cancer in patients followed first and subsequen

Material and method.

In study, 928 males were included, in which 6-12 core, transrectal ultrasound guided prostate biopsy
was preformed. In patients with ASAP or PIN in first biopsy, or suspected for cancer development, second biopsy (extended to 10-16 cores) was preformed in period of 4-6 months.

Results.

Prostate cancer was found in 300 (32.3%) patients, and precancerous lesions (ASAP, HG-PIN) in 135 (14.54%), from which ASAP in 50 (5.38%), HG-PIN in 68 (7.32%) and its co-existence in 17 (1.83%). Co-existence of cancer and ASAP was found in 12 (4%) of 300 males, and HG-PIN and cancer in 24 (8%), with statistical difference. Mean PSA level was no different in ASAP and HG-PIN groups. Following biopsy was performed in 78 patients, founding cancer in 11 (14.1%), from which 4 out of 15 (26.6%) of patients with HG-PIN on first biopsy, and 3 out of 40 (7.5%) with BPH, and 4 out of 19 (21.05%) with ASAP, or ASAP co-existing with LG-PIN, and 1 out of 2 (50%) with co-existence of ASAP and HG-PIN on first biopsy. There was no cancer found on second biopsy, in patients with LG-PIN on first, as well as when prostate inflammation accompanied other lesion. Cancer found in following biopsy in patients with HG-PIN on first, had usually higher Gleason score (7-10), than those found in patients with ASAP on first (score 4-6).

Conclusions.

1. Patients with ASAP or HG-PIN on initial biopsy are similarly suspected to develop prostate cancer.
2. Co-incidence of prostate cancer and HG-PIN was higher than cancer and ASAP.
3. There was no incidence of cancer found on following biopsy in patients with LG-PIN on first, as well as any other lesion combined together with prostate inflammation.
4. PSA level in ASAP and HG-PIN were not significantly different, and usually were higher than 10 ng/ml.

references

  1. Jemal A, Tiwari RC, Murray T: Cancer statistics 2004. CA Cancer J Clin 2004, 54, 8-29. Didkowska J, Wojciechowska U, Tarkowski W, Zatoński W: Nowotwory złośliwe w Polsce w 2000 roku, Zakład Epidemiologii i Prewencji Nowotworów Centrum Onkologii – Instytut im. M. Skłodowskiej-Curie. Warszawa, 2003, 84-86; 100-102.
  2. Jensen OM, Esteve J, Moller H, Renard H: Cancer in European community and its member states. Eur J Cancer 1990, 26, 1167-1256.
  3. Pearson JD, Carter HB: Natural history of changes in prostate specific antigen in early stage prostate cancer. J Urol 1994, 152, 1743-1748.
  4. Tibblin G, Welin L, Bergström R, Ronquist G, Norlén BJ, Adami HO. The value of prostate specific antigen in early diagnosis of prostate cancer. The study of men born in 1913. J Urol 1995, 154, 1386-1389.
  5. Bostwick DG, Brawer MK: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987, 15, 59, 788-794.
  6. Bostwick DG: Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem Suppl 1992, 16, 10-19.
  7. Bostwick DG, Pacelli A, Lopez-Beltran A: Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996, 29, 117-134.
  8. Bostwick DG: High grade intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer 1995, 75, 1823-1836.
  9. Bostwick DG: Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 1996, 78, 330-336.
  10. Ouyang RC, Kenwright DN, Nacey JN, Delahunt B: The presence of atypical small acinar proliferation in prostate needle biopsy is predictive of carcinoma on subsequent biopsy. BJU International 2001, 87, 70-74.
  11. Iczkowski KA, Bassler TJ, Schwob VS, Bassler IC: Diagnosis of ‘‘suspicious for malignancy’’ in prostate biopsies: predictive value for cancer. Urology 1998, 51, 749-757.
  12. Iczkowski KA, Bostwick DG: Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma. Arch Pathol Lab Med, 2000, 124, 98-107.
  13. Iczkowski KA, Chen HM, Yang XJ: Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology 2002, 60, 851-854.
  14. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL: Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000, 163, 158-162.
  15. Moore CK, Karikehalli S, Nazeer T, Fisher HA et al: Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005, 173,70-72.
  16. Dobruch J, Modzelewska E, Popiel M i in: Stopień klinicznego zaawansowania raka stercza w momencie rozpoznania. Urol Pol 2006, 59, 4, 21-25.
  17. Raviv G, Zlotta AR, Janssen T et al: Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? Cancer 1996, 15, 77, 2103-2108.
  18. Schlesinger C, Bostwick DG, Iczkowski KA: High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol 2005, 29, 1201-1207.
  19. Horninger W, Volgger H, Rogatsch H et al: Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project. J Urol 2001, 165, 1143-1145.
  20. Scattoni V, Roscigno M, Freschi M et al: Atypical small acinar proliferation (ASAP) on initial extended prostate biopsy: cancer detection on second and third extended biopsy. Arch Ital Urol Androl 2005, 77, 31-36.
  21. Chan TY, Epstein JI: Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology 1999, 53, 351-355.
  22. Keetch DW, Humphrey P, Stahl D et al: Morphometric analysis and clinical follow up of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 1995, 154, 347-351.
  23. Chrisofos M, Papatsoris AG, Lazaris A, Deliveliotis C: Precursor Lesions of Prostate Cancer Crit Rev Clin Lab Sci 2007;44(3):243-70
  24. Djavan B, Zlotta A, Remzi M et al: Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1051 men. J Urol 2000,163,1144-1149.
  25. Schoenfield L, Jones JS, Zippe CD et al: The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int 2007, 99, 770-774.
  26. Wolski Z, Pokrywka Ł, Bryczkowski M i in: Badanie stercza palcem przez odbytnicę (DRE) jako wstępna ocena stadium miejscowego zaawansowania raka u pacjentów kwalifikowanych do prostatektomii radykalnej. Urol Pol 2007, 60, 38-41.
  27. Wolters T, Roobol M, Roemeling S et al: Long-term followed-up of highgrade prostatic intraepithelial neoplasia and atypical foci suspicious for carcinoma on sextant prostate nedle biopsy, European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol Suppl 2007, 6, 123.

correspondence

Przemysław Adamczyk
Specjalistyczny Szpital Miejski
Oddział Urologii Ogólnej i Onkologicznej
ul. Batorego 17/19
87-100 Toruń
tel. (056) 610 02 54
przemekad@poczta.onet.pl